Melissa Baird, the Chief Operating Officer of Hims & Hers Health Inc (NYSE:HIMS), has sold 35,253 shares of the company on March 7, 2024, according to a recent SEC filing. The transaction was executed at an average price of $14.19 per share, resulting in a total value of $500,291.07.
Hims & Hers Health Inc is a telehealth company that provides a modern approach to health and wellness. The company's platform connects consumers with licensed healthcare professionals, enabling them to access high-quality care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Hims & Hers Health Inc aims to make healthcare more accessible and convenient through its telehealth services.
Melissa Baird’s recent sale is part of a series of transactions over the past year, during which the insider has sold a total of 362,026 shares and has not made any purchases of the company's stock.
The insider transaction history for Hims & Hers Health Inc shows a pattern of insider selling, with 62 insider sells and no insider buys over the past year.
On the valuation front, Hims & Hers Health Inc's shares were trading at $14.19 on the day of the insider's recent sale, giving the company a market capitalization of $3.074 billion.
With a current price of $14.19 and a GuruFocus Value of $12.50, Hims & Hers Health Inc is considered modestly overvalued with a price-to-GF-Value ratio of 1.14.
The GF Value is determined by considering historical trading multiples, a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates provided by Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
